Pzena Investment Management LLC Invests $45.31 Million in Varex Imaging $VREX

Pzena Investment Management LLC acquired a new stake in Varex Imaging (NASDAQ:VREX) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 4,344,381 shares of the company’s stock, valued at approximately $45,312,000. Pzena Investment Management LLC owned 10.32% of Varex Imaging as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in VREX. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Varex Imaging in the 4th quarter worth about $1,247,000. LSV Asset Management increased its stake in shares of Varex Imaging by 210.7% during the 4th quarter. LSV Asset Management now owns 1,244,329 shares of the company’s stock valued at $14,496,000 after acquiring an additional 843,805 shares during the last quarter. Rice Hall James & Associates LLC lifted its holdings in shares of Varex Imaging by 19.1% during the 4th quarter. Rice Hall James & Associates LLC now owns 1,082,964 shares of the company’s stock worth $12,617,000 after acquiring an additional 173,703 shares during the period. Sei Investments Co. lifted its holdings in shares of Varex Imaging by 72.5% during the 1st quarter. Sei Investments Co. now owns 411,655 shares of the company’s stock worth $4,368,000 after acquiring an additional 173,041 shares during the period. Finally, Legato Capital Management LLC boosted its position in shares of Varex Imaging by 889.9% in the fourth quarter. Legato Capital Management LLC now owns 99,810 shares of the company’s stock worth $1,163,000 after acquiring an additional 89,727 shares during the last quarter.

Varex Imaging Stock Down 0.2%

Shares of NASDAQ:VREX opened at $18.46 on Tuesday. The stock has a 50-day simple moving average of $11.77 and a 200-day simple moving average of $11.70. The stock has a market capitalization of $777.17 million, a P/E ratio of 35.50 and a beta of 0.89. Varex Imaging has a 1 year low of $9.09 and a 1 year high of $18.63. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.53 and a current ratio of 3.38.

Varex Imaging (NASDAQ:VREX) last posted its quarterly earnings results on Monday, August 10th. The company reported $0.31 EPS for the quarter, beating the consensus estimate of $0.21 by $0.10. The firm had revenue of $210.50 million for the quarter, compared to analyst estimates of $215.50 million. Varex Imaging had a net margin of 2.55% and a return on equity of 9.19%. Equities analysts forecast that Varex Imaging will post 0.93 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the stock. Wall Street Zen upgraded shares of Varex Imaging from a “hold” rating to a “buy” rating in a report on Saturday, July 4th. B. Riley Financial downgraded shares of Varex Imaging from a “buy” rating to a “hold” rating in a research note on Monday, August 10th. CJS Securities lowered shares of Varex Imaging from an “outperform” rating to a “market perform” rating in a report on Monday. Weiss Ratings raised shares of Varex Imaging from a “sell (d-)” rating to a “sell (d+)” rating in a research note on Tuesday, August 11th. Finally, Oppenheimer downgraded Varex Imaging from an “outperform” rating to a “market perform” rating in a report on Monday, August 10th. Six analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Reduce” and an average target price of $16.88.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.